Research Article
[Retracted] Downregulated Expression of miRNA-130a-5p Aggravates Hepatoma Progression via Targeting PTP4A2
Table 1
Correlations between miRNA-130a-5p and the clinicopathological parameters of hepatoma patients (
, test).
| Variable | MiRNA-130a-5p expression | value | High | Low | 20 | 20 |
| Age (year) | | | 0.097 | <60 | 10 | 4 | | ≥60 | 10 | 16 | | Gender | | | 0.723 | Female | 6 | 5 | | Male | 14 | 15 | | Tumor size | | | 0.004 | <5 cm | 6 | 16 | | ≥5 cm | 14 | 4 | | TNM stage | | | 0.011 | I–II | 7 | 16 | | III–IV | 13 | 4 | | Liver cirrhosis | | | 0.677 | Yes | 16 | 17 | | No | 4 | 3 | | AFP (ng/mL) | | | 0.157 | ≤200 | 12 | 17 | | >200 | 8 | 3 | | HBsAg | | | 0.273 | Positive | 17 | 13 | | Negative | 3 | 7 | | Edmondson grade | | | 0.024 | I–II | 8 | 16 | | III–IV | 12 | 4 | | | | | |
|
|